CIDRAP newsletters options
Once the CDC gives the nod, distribution will start this week, with 2 million doses allocated to states.
The move gives the US a third vaccine to fight the pandemic—one that offers an easier, one-dose option that does not have to be frozen.
Now open for public comment, the WHO-led roadmap has 14 goals.
"We are left with evidence of benefit from interleukin-6 inhibitors, at least under some circumstances."
Now, it's up to FDA officials to make a final decision, which could come tomorrow.
Ten percent of cases are now caused by B117, up from 1% to 4% a few weeks ago.
In addition to less antibiotic use, participating hospitals saw a 20% drop in hospital-onset C difficile.
Five residents of a skilled nursing facility in Kentucky were likely reinfected with COVID-19, and the disease was worse the second time, with one patient dying, according to today's Morbidity and Mortality Weekly Report (MMWR).
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Feb 25
The World Health Organization (WHO) today announced that its influenza vaccine strain selection committee has made its recommendations for the Northern Hemisphere's 2021-22 flu season, which swaps out the two influenza A strains for both the egg-based and cell-based or recombinant vaccines.
MIS-C patients were almost twice as likely to have no underlying medical conditions.
The New York variant carries a mutation that may lower vaccine protection, and the California one has become widespread.
Leaders of some countries warned that spiking cases amid the spread of variant viruses will put intense pressure on health systems.
A nationwide study in Denmark found an association between the use of proton pump inhibitors (PPIs) and increased risk of community-associated Clostridioides difficile infections (CA-CDI), Danish researcher reported today in Clinical Infectious Diseases.
A survey of US registered dental hygienists reported that 3.1% had been diagnosed as having COVID-19 as of October 2020, according to a Journal of Dental Hygiene study published yesterday. At the time, the study says an estimated 2.3% of the general US population had been infected.
In other good news, the CDC says case levels have dropped to summertime levels.
In other developments, global COVID-19 cases fell for the sixth week in a row.
Two doses were 92% effective in preventing infection, but 1 dose was 74% effective against COVID-related hospitalization and 72% effective at preventing death.
The European Centre for Disease Prevention and Control (ECDC) today issued a risk assessment regarding human H5N8 avian flu cases reported recently in Russia, with the caveat that it was basing its report on very limited data.
Russia recently reported seven infections in people who worked at poultry facilities in the south. They reportedly had asymptomatic infections, and no human-to-human transmission was noted.
Americans with COVID-19 antibodies displayed 10-fold increased protection against infection 90 days after testing compared with those who had no antibodies, according to a study published today in JAMA Internal Medicine.
